Humanetics Presents BIO 300 Radiation Countermeasure Data at DoD Scientific Meeting Medical Countermeasures October 3, 2024 …
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 Medical Countermeasures May 6, 2024 …
ReAlta Development of RLS-0071 as Acute Radiation Syndrome Medical Countermeasure Medical Countermeasures March 28, 2024 …
NIAID Funding Development of Biomarkers and Tools for Radiation Emergency Triage Medical Countermeasures January 25, 2024 …
RedHill Biopharma Highlights Federal Medical Countermeasure Investments Industry News August 17, 2023 …
NIAID Awards Multiple Contracts for Radiation Medical Countermeasures and Biodosimetry CBRNE July 9, 2023 …
UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism CBRNE August 24, 2022 …
Understanding How the Microbiome Affects Radiation Injury for Countermeasure Development CBRNE October 11, 2021 …
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA Industry News October 3, 2021 …
Humanetics’ Radiation Medical Countermeasure Receives FDA Fast Track Designation CBRNE August 24, 2021 …
RFI Supports Research on Impact of Nuclear Incident on the Microbiome and Development of Targeted Therapeutics CBRNE June 6, 2021 …
High-Throughput Automated Biodosimetry in Response to a Large-Scale Radiological Event CBRNE February 19, 2020 …
Humanetics Corporation Acquires Manufacturing Assets for Radioprotectant Drug CBRNE February 19, 2020 …
